2m 2m 2m 2m 2m 2m 2m
X4 PHARMA (XFOR)
NASDAQ
$3.21-$0.02 (-0.77%)
Price as of Nov 12, 2026 7:38 AM EST- $329.8MMarket Cap
- -16.54%1-Year Change
- BiotechnologyIndustry
X4 PHARMA (XFOR)
$3.21-$0.02 (-0.77%)
XFOR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.23 | ||
Change | -$0.02 (-0.46%) | ||
Open | $3.27 | ||
High | $3.36 | ||
Low | $3.17 | ||
Previous Close | $3.25 | ||
Volume | 776,136 | ||
30-Day Average Volume | 661,920 | ||
1-Week Change | -0.31% | ||
1-Month Change | 11.00% | ||
1-Year Change | -16.54% | ||
3-Year Change | -85.65% | ||
5-Year Change | -97.74% | ||
Fundamentals | |||
Shares Outstanding | 102.1M | ||
Total Assets | $231.8M | ||
Market Cap | $329.8M | ||
Enterprise Value | $219.0M | ||
Period: QTR TTM FY | |||
Revenue | $106,000.00 | ||
Net Income | -$20.2M | ||
Free Cash Flow | -$20.2M | ||
EBIT | -$18.0M | ||
EBITDA | -$17.7M | ||
Net Working Capital | $183.2M | ||
EPS | -$0.16 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 2,066 | ||
P/B | 2 | ||
P/E | -20 | ||
PEG | 1 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 04/28/2025 | ||
Earnings & Revenue